A St. Louis jury awarded $70 million to a California woman in the latest verdict against Baby Powder manufacturer Johnson & Johnson for its role in causing her ovarian cancer diagnosis.
The woman was diagnosed with ovarian cancer in 2012, following her extended use of talcum powder, the main ingredient in Johnson & Johnson’s Baby Powder. The lawsuit stated Johnson & Johnson acted negligently in its failure to warn consumers that using its talc based products for feminine hygiene could raise ovarian cancer risks.
The October verdict is the third to be handed down by St. Louis juries in 2016. Two talcum powder cases tried earlier this year resulted in verdicts of $72 million and $55 million.
While Johnson & Johnson has expressed its sympathies for the woman’s diagnosis, they plan to appeal the verdict, and they continue to claim their products are safe and do not cause ovarian cancer.
To date, research has failed to support a direct correlation between talcum based powder use and an ovarian cancer diagnosis, however, studies dating back to the 1970s have linked talcum powder use to increased risks of ovarian cancer.
During the latest trial, attorneys cited research to support the dangers associated with talcum based powder use and women regularly applying talc to their genital area faced ovarian cancer risks 40 percent higher than those who do not use talcum powder based products.
Additionally, attorneys in this case also alleged that Johnson & Johnson specifically marketed talcum powder products to groups of women most at-risk for developing ovarian cancer.
Have you or a loved one been diagnosed with ovarian cancer after regular user of talcum powder products? You may be entitled to compensation for your medical bills, lost wages, and pain and suffering. Contact the class action lawyers at Brunson, Barnett & Sherrer, PC to find out if you have a case.